Eight members of the National Institutes of Health (NIH) expert COVID-19 Treatment Guidelines Panel disclosed recent financial relationships with Gilead, the drugmaker that is introducing an expensive Coronavirus competitor to Hydroxychloroquine, the inexpensive anti-malarial drug that President Trump has promoted which many people claim has helped them. This financial relationship between NIH experts and Gilead is especially concerning in light of*revelations that NIH has a financial stake in the Bill Gates-funded Moderna vaccine, another competitor to Hydroxychloroquine.Chloroquine critic Dr. Anthony Fauci’s NIAID, which*funded the Bat Coronavirus research at the Wuhan Institute of Virologybelieved to be the source of the outbreak, is part of NIH.
https://www.covid19treatmentguidelines.nih.gov/panel-financial-disclosure/
https://www.covid19treatmentguidelines.nih.gov/panel-financial-disclosure/
Comment